Editorial: Prebiotics in the Management of Obesity and Associated Metabolic Disorders
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Sket R, Slapnik B, Kotnik P, crepinsek K, cugalj Kern B, Tesovnik T Adv Ther. 2024; 42(1):72-93.
PMID: 39535684 PMC: 11782414. DOI: 10.1007/s12325-024-03057-8.
References
1.
. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024; 403(10431):1027-1050.
PMC: 7615769.
DOI: 10.1016/S0140-6736(23)02750-2.
View
2.
Albillos A, De Gottardi A, Rescigno M
. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol. 2019; 72(3):558-577.
DOI: 10.1016/j.jhep.2019.10.003.
View
3.
Sagar N, Tarafdar S, Agarwal S, Tarafdar A, Sharma S
. Polyamines: Functions, Metabolism, and Role in Human Disease Management. Med Sci (Basel). 2021; 9(2).
PMC: 8293435.
DOI: 10.3390/medsci9020044.
View
4.
Chen J, Liu J, Yan C, Zhang C, Pan W, Zhang W
. Sarcodon aspratus polysaccharides ameliorated obesity-induced metabolic disorders and modulated gut microbiota dysbiosis in mice fed a high-fat diet. Food Funct. 2020; 11(3):2588-2602.
DOI: 10.1039/c9fo00963a.
View
5.
Ramakrishna B
. Role of the gut microbiota in human nutrition and metabolism. J Gastroenterol Hepatol. 2013; 28 Suppl 4:9-17.
DOI: 10.1111/jgh.12294.
View